Frank Grassler, JD
Frank Grassler is an intellectual property and regulatory attorney and licensing executive with over 30 years of biopharma industry experience in law and business, covering preparation/prosecution, licensing, technology transfer, start-ups, acquisitions, portfolio management, and people management, as well as patent litigation, for IP and technology transfer departments. His technical areas have included chemical, biological, genetic, and mechanical inventions, including pharmaceuticals, biologicals, vaccines, monoclonal antibodies, clinical trial outcomes, novel materials, and mechanical & electromechanical devices. His regulatory work has covered university & hospital research, development, and clinical programs and compliance with FDA, HIPAA, and FCPA. His affiliations include Gates Corporation, G. D. Searle, Merck, GlaxoSmithKline, Gilead Sciences, Genentech/Roche and the University of Texas Southwestern Medical Center where he currently serves as Vice President for Technology Development.